{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:13:36Z","timestamp":1791278016737,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1378\/chest.14-1997","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T09:30:47Z","timestamp":1426152647000},"page":"533-542","source":"Crossref","is-referenced-by-count":53,"title":["The Evolution of Cystic Fibrosis Care"],"prefix":"10.1016","volume":"148","author":[{"given":"Jessica E.","family":"Pittman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Ferkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.14-1997_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1378\/chest.14-1997_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-pathol-011811-120900","article-title":"Genetic variation and clinical heterogeneity in cystic fibrosis","volume":"7","author":"Drumm","year":"2012","journal-title":"Annu Rev Pathol"},{"issue":"5899","key":"10.1378\/chest.14-1997_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/301421a0","article-title":"Chloride impermeability in cystic fibrosis","volume":"301","author":"Quinton","year":"1983","journal-title":"Nature"},{"issue":"5","key":"10.1378\/chest.14-1997_bib4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI110894","article-title":"Relative ion permeability of normal and cystic fibrosis nasal epithelium","volume":"71","author":"Knowles","year":"1983","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1378\/chest.14-1997_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI6222","article-title":"The genesis of cystic fibrosis lung disease","volume":"103","author":"Wine","year":"1999","journal-title":"J Clin Invest"},{"issue":"9636","key":"10.1378\/chest.14-1997_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(08)61162-9","article-title":"Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis","volume":"372","author":"Quinton","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1378\/chest.14-1997_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J Clin Invest"},{"issue":"7405","key":"10.1378\/chest.14-1997_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"issue":"4922","key":"10.1378\/chest.14-1997_bib9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"4922","key":"10.1378\/chest.14-1997_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis.","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"12","key":"10.1378\/chest.14-1997_bib11","doi-asserted-by":"crossref","first-page":"a009548","DOI":"10.1101\/cshperspect.a009548","article-title":"The influence of genetics on cystic fibrosis phenotypes","volume":"2","author":"Knowles","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1378\/chest.14-1997_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0025-7125(05)70243-1","article-title":"Genotype-phenotype relationships in cystic fibrosis","volume":"84","author":"Mickle","year":"2000","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1378\/chest.14-1997_bib13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"10.1378\/chest.14-1997_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.ge.29.120195.004021","article-title":"Cystic fibrosis: genotypic and phenotypic variations","volume":"29","author":"Zielenski","year":"1995","journal-title":"Annu Rev Genet"},{"issue":"4","key":"10.1378\/chest.14-1997_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"issue":"6282","key":"10.1378\/chest.14-1997_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/346366a0","article-title":"A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein","volume":"346","author":"Cutting","year":"1990","journal-title":"Nature"},{"issue":"5039","key":"10.1378\/chest.14-1997_bib17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1126\/science.1722350","article-title":"Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes","volume":"254","author":"Drumm","year":"1991","journal-title":"Science"},{"issue":"3","key":"10.1378\/chest.14-1997_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1193-274","article-title":"A mutation in CFTR produces different phenotypes depending on chromosomal background","volume":"5","author":"Kiesewetter","year":"1993","journal-title":"Nat Genet"},{"issue":"3","key":"10.1378\/chest.14-1997_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3476(76)80537-9","article-title":"Course of cystic fibrosis in 95 patients","volume":"89","author":"Stern","year":"1976","journal-title":"J Pediatr"},{"issue":"4","key":"10.1378\/chest.14-1997_bib20","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jpeds.2013.05.013","article-title":"Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function","volume":"163","author":"Morgan","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"10.1378\/chest.14-1997_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.prrv.2008.04.002","article-title":"Genetic and non-genetic determinants of outcomes in cystic fibrosis.","volume":"10","author":"Wolfenden","year":"2009","journal-title":"Paediatr Respir Rev"},{"issue":"6","key":"10.1378\/chest.14-1997_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-2004-815660","article-title":"Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions","volume":"24","author":"Schechter","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1378\/chest.14-1997_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ppul.10100","article-title":"Predictors of deterioration of lung function in cystic fibrosis","volume":"33","author":"Schaedel","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1378\/chest.14-1997_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200306-779OC","article-title":"Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis","volume":"169","author":"Goss","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.14-1997_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ppul.21279","article-title":"Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort","volume":"45","author":"Rosenfeld","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"10.1378\/chest.14-1997_bib26","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.201307-1268OC","article-title":"Air trapping and airflow obstruction in newborn cystic fibrosis piglets","volume":"188","author":"Adam","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6198","key":"10.1378\/chest.14-1997_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Cystic fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1378\/chest.14-1997_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/thx.2010.139493","article-title":"Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis","volume":"66","author":"Ranganathan","year":"2011","journal-title":"Thorax"},{"issue":"5","key":"10.1378\/chest.14-1997_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejcn.2013.20","article-title":"Nutritional care in children with cystic fibrosis: are our patients becoming better?","volume":"67","author":"Gaskin","year":"2013","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"10.1378\/chest.14-1997_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"issue":"2","key":"10.1378\/chest.14-1997_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.14-1997_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.prrv.2008.05.009","article-title":"Role of high-resolution computed tomography in the detection of early cystic fibrosis lung disease","volume":"9","author":"Linnane","year":"2008","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1378\/chest.14-1997_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1378\/chest.14-1997_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1378\/chest.14-1997_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/mpd.2001.112897","article-title":"Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis","volume":"138","author":"Nixon","year":"2001","journal-title":"J Pediatr"},{"issue":"7","key":"10.1378\/chest.14-1997_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nm0795-661","article-title":"The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain","volume":"1","author":"Sun","year":"1995","journal-title":"Nat Med"},{"issue":"1","key":"10.1378\/chest.14-1997_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcf.2011.07.008","article-title":"Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis","volume":"11","author":"Waters","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1378\/chest.14-1997_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2012.12.006","article-title":"Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients","volume":"12","author":"Waters","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1378\/chest.14-1997_bib39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.14-1997_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1378\/chest.14-1997_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MCP.0b013e328358d49a","article-title":"The cystic fibrosis airway microbiome","volume":"18","author":"Rabin","year":"2012","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1378\/chest.14-1997_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clnu.2014.04.004","article-title":"The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies","volume":"33","author":"Li","year":"2014","journal-title":"Clin Nutr."},{"issue":"1","key":"10.1378\/chest.14-1997_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mib.2011.11.001","article-title":"Bacterial host interactions in cystic fibrosis","volume":"15","author":"Callaghan","year":"2012","journal-title":"Curr Opin Microbiol"},{"issue":"8","key":"10.1378\/chest.14-1997_bib44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Crit Care Med"},{"issue":"12","key":"10.1378\/chest.14-1997_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/thoraxjnl-2013-203204","article-title":"Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications","volume":"68","author":"Cohen-Cymberknoh","year":"2013","journal-title":"Thorax"},{"key":"10.1378\/chest.14-1997_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1378\/chest.14-1997_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI35138","article-title":"Gene modifiers in cystic fibrosis","volume":"118","author":"Accurso","year":"2008","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1378\/chest.14-1997_bib48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis","volume":"353","author":"Drumm","year":"2005","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1378\/chest.14-1997_bib49","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.14-1997_bib50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.07-1631","article-title":"Airway inflammation in cystic fibrosis","volume":"133","author":"Elizur","year":"2008","journal-title":"Chest"},{"key":"10.1378\/chest.14-1997_bib51","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3476(64)80290-0","article-title":"A therapeutic regimen for patients with cystic fibrosis","volume":"65","author":"Matthews","year":"1964","journal-title":"J Pediatr"},{"issue":"9","key":"10.1378\/chest.14-1997_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.14-1997_bib53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1378\/chest.14-1997_bib54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.14-1997_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V","article-title":"Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis","volume":"28","author":"Rosenfeld","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1378\/chest.14-1997_bib56","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1164\/rccm.200603-343OC","article-title":"Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis","volume":"175","author":"Davis","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.14-1997_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2011.954","article-title":"Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial","volume":"306","author":"Wainwright","year":"2011","journal-title":"JAMA"},{"issue":"18","key":"10.1378\/chest.14-1997_bib58","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.14-1997_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1513\/pats.200703-041BR","article-title":"Endpoints for clinical trials in young children with cystic fibrosis","volume":"4","author":"Davis","year":"2007","journal-title":"Proc Am Thorac Soc"},{"issue":"6","key":"10.1378\/chest.14-1997_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"issue":"suppl 6","key":"10.1378\/chest.14-1997_bib61","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"issue":"2","key":"10.1378\/chest.14-1997_bib62","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1513\/AnnalsATS.201301-017ST","article-title":"An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age","volume":"10","author":"Rosenfeld","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1378\/chest.14-1997_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1378\/chest.14-1997_bib64","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/thx.2010.150375","article-title":"Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF","volume":"66","author":"Owens","year":"2011","journal-title":"Thorax"},{"issue":"9","key":"10.1378\/chest.14-1997_bib65","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/thx.49.9.863","article-title":"Critical evaluation of three chest radiograph scores in cystic fibrosis","volume":"49","author":"Sawyer","year":"1994","journal-title":"Thorax"},{"issue":"10","key":"10.1378\/chest.14-1997_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/RLI.0b013e318074fd81","article-title":"Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray","volume":"42","author":"Puderbach","year":"2007","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1378\/chest.14-1997_bib67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld","year":"2001","journal-title":"J Pediatr"},{"issue":"10","key":"10.1378\/chest.14-1997_bib68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.14-1997_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpeds.2005.10.019","article-title":"Cystic fibrosis pulmonary exacerbations","volume":"148","author":"Ferkol","year":"2006","journal-title":"J Pediatr"},{"issue":"5","key":"10.1378\/chest.14-1997_bib70","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.14-1997_bib71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1479972312445903","article-title":"Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations","volume":"9","author":"Sequeiros","year":"2012","journal-title":"Chron Respir Dis"},{"key":"10.1378\/chest.14-1997_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-11-137","article-title":"Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations","volume":"11","author":"VanDevanter","year":"2010","journal-title":"Respir Res"},{"issue":"9","key":"10.1378\/chest.14-1997_bib73","doi-asserted-by":"crossref","first-page":"e45001","DOI":"10.1371\/journal.pone.0045001","article-title":"The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations","volume":"7","author":"Fodor","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1378\/chest.14-1997_bib74","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1164\/rccm.200309-1306OC","article-title":"Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa","volume":"169","author":"Aaron","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 2","key":"10.1378\/chest.14-1997_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2005.05.018","article-title":"Eradication of early Pseudomonas aeruginosa infection","volume":"4","author":"H\u00f8iby","year":"2005","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1378\/chest.14-1997_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis","volume":"23","author":"Frederiksen","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1378\/chest.14-1997_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1378\/chest.14-1997_bib78","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1517\/14656566.2013.790366","article-title":"Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials","volume":"14","author":"M\u00e1iz","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1378\/chest.14-1997_bib79","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1513\/AnnalsATS.201311-395FR","article-title":"Inhaled antibiotics for lower airway infections","volume":"11","author":"Quon","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"9","key":"10.1378\/chest.14-1997_bib80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1164\/rccm.201301-0184UP","article-title":"Update in cystic fibrosis 2012","volume":"187","author":"Goss","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.14-1997_bib81","first-page":"CD002011","article-title":"Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis","author":"Main","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1378\/chest.14-1997_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000194251","article-title":"Short-term effects of chest physiotherapy on pulmonary function in children with cystic fibrosis","volume":"40","author":"Weller","year":"1980","journal-title":"Respiration"},{"issue":"6","key":"10.1378\/chest.14-1997_bib83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J Pediatr"},{"issue":"6","key":"10.1378\/chest.14-1997_bib84","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ppul.21388","article-title":"Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis","volume":"46","author":"Konstan","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1378\/chest.14-1997_bib85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.1999.tb01265.x","article-title":"Systematic review of N-acetylcysteine in cystic fibrosis","volume":"88","author":"Duijvestijn","year":"1999","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1378\/chest.14-1997_bib86","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.14-1997_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1378\/chest.14-1997_bib88","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/jama.2012.5214","article-title":"Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial","volume":"307","author":"Rosenfeld","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1378\/chest.14-1997_bib89","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1378\/chest.07-2294","article-title":"Inhaled mannitol improves lung function in cystic fibrosis","volume":"133","author":"Jaques","year":"2008","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.14-1997_bib90","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.09-2017","article-title":"Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis","volume":"137","author":"Daviskas","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.14-1997_bib91","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.200608-1238OC","article-title":"Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis","volume":"176","author":"Deterding","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1378\/chest.14-1997_bib92","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jcf.2012.05.003","article-title":"Long term effects of denufosol tetrasodium in patients with cystic fibrosis","volume":"11","author":"Ratjen","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1378\/chest.14-1997_bib93","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpeds.2012.11.034","article-title":"Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis","volume":"162","author":"Moss","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"10.1378\/chest.14-1997_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/18744672112059990025","article-title":"ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art","volume":"6","author":"Althaus","year":"2013","journal-title":"Curr Mol Pharmacol"},{"issue":"6","key":"10.1378\/chest.14-1997_bib95","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ppul.20294","article-title":"Lower airway inflammation in infants with cystic fibrosis detected by newborn screening","volume":"40","author":"Armstrong","year":"2005","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1378\/chest.14-1997_bib96","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0169-409X(02)00146-1","article-title":"Pharmacological approaches for the discovery and development of new antiinflammatory agents for the treatment of cystic fibrosis","volume":"54","author":"Konstan","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1378\/chest.14-1997_bib97","first-page":"CD001505","article-title":"Oral non-steroidal antiinflammatory drug therapy for lung disease in cystic fibrosis","volume":"6","author":"Lands","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1378\/chest.14-1997_bib98","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-1997_bib99","first-page":"CD000407","article-title":"Oral steroids for long-term use in cystic fibrosis","volume":"6","author":"Cheng","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1378\/chest.14-1997_bib100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpeds.2008.07.010","article-title":"Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis","volume":"153","author":"Ren","year":"2008","journal-title":"J Pediatr"},{"issue":"13","key":"10.1378\/chest.14-1997_bib101","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA."},{"issue":"17","key":"10.1378\/chest.14-1997_bib102","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1378\/chest.14-1997_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.12-1639","article-title":"Cystic fibrosis therapeutics: the road ahead","volume":"143","author":"Hoffman","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.14-1997_bib104","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03256628","article-title":"Current status of gene therapy for cystic fibrosis pulmonary disease","volume":"1","author":"Kennedy","year":"2002","journal-title":"Am J Respir Med"},{"issue":"2","key":"10.1378\/chest.14-1997_bib105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1378\/chest.14-1997_bib107","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","article-title":"Ataluren for the treatment of nonsensemutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial","volume":"2","author":"Kerem","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"18","key":"10.1378\/chest.14-1997_bib108","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-1997_bib109","author":"KALYDECO"},{"issue":"1","key":"10.1378\/chest.14-1997_bib110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"issue":"246","key":"10.1378\/chest.14-1997_bib111","doi-asserted-by":"crossref","first-page":"246ra96","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of \u0394F508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci Transl Med"},{"issue":"246","key":"10.1378\/chest.14-1997_bib112","doi-asserted-by":"crossref","first-page":"246ra97","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci Transl Med"},{"issue":"suppl 3","key":"10.1378\/chest.14-1997_bib113","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1513\/AnnalsATS.201312-444LD","article-title":"Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases","volume":"11","author":"Pittman","year":"2014","journal-title":"Ann Am Thorac Soc"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:27:39Z","timestamp":1537781259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215503504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0012369215503504"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-1997","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}